Your browser doesn't support javascript.
loading
Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
Ludwig, H; Milosavljevic, D; Zojer, N; Faint, J M; Bradwell, A R; Hübl, W; Harding, S J.
Affiliation
  • Ludwig H; Wilhelminenhospital Department of Medicine I, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria. heinz.ludwig@wienkav.at
Leukemia ; 27(1): 213-9, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22955329

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Biomarkers / Immunoglobulin Heavy Chains / Immunoglobulin Light Chains / Neoplasm, Residual / Monitoring, Physiologic / Multiple Myeloma Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Austria Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Biomarkers / Immunoglobulin Heavy Chains / Immunoglobulin Light Chains / Neoplasm, Residual / Monitoring, Physiologic / Multiple Myeloma Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Austria Country of publication: United kingdom